Dopamine Agents (administration & dosage) < Dopamine Agents (adverse effects) < Dopamine Agents (blood)

Facettes :

List of bibliographic references indexed by Dopamine Agents (adverse effects)

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000398 (2016)	Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau	D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000407 (2016)	A Jon Stoessl [Canada]	Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
000599 (2015)	Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada]	Parkinson's disease.
000630 (2015)	Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput	Neuroleptic‐induced Parkinsonism: Clinicopathological study
000C43 (2013)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
000D19 (2013)	Susan H. Fox [Canada]	Non-dopaminergic treatments for motor control in Parkinson's disease.
000F63 (2013)	Alex A. Macdonald [Canada] ; Oury Monchi [Canada] ; Ken N. Seergobin [Canada] ; Hooman Ganjavi [Canada] ; Ruzbeh Tamjeedi [Canada] ; Penny A. Macdonald [Canada]	Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function
001473 (2012)	Alain Dagher [Canada]	ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE
001679 (2011)	James K R. Stevenson [Canada] ; Pouria Talebifard ; Edna Ty ; Meeko M K. Oishi ; Martin J. Mckeown	Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication.
001A50 (2010)	Janis M. Miyasaki [Canada]	Evidence-based initiation of dopaminergic therapy in Parkinson's disease.
001C52 (2010)	A. Jon Stoessl [Canada]	Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
002204 (2008)		Dopamine agonist: pathological gambling and hypersexuality.
002883 (2006)	Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon Stoessl	Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
002B55 (2004)	Harold D. Foster [Canada] ; Abram Hoffer	The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
002C32 (2004)	Rau L De La Fuente-Ferna Ndez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model
003363 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003558 (2000)	A. E. Lang [Canada] ; LANGSTON ; RASCOL ; BROTCHIE ; BENABID ; MELAMED ; BONUCELLI ; OLANOW ; OBESO ; GIMENEZ-ROLDAN ; RAJPUT ; FAHN ; NUTT ; BROOKS ; CHASE	Surgery for levodopa-induced dyskinesias. Discussion
003566 (2000)	M. Filion [Canada] ; OBESO ; BENABID ; OLANOW ; LANG ; HIRSCH ; NUTT	Physiologic basis of dyskinesia. Discussion
003578 (2000)	F. Calon [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; T. T. Di Paolo [Canada] ; P. J. Bedard [Canada]	Molecular basis of levodopa-induced dyskinesias
004629 (1992)	H. A. Robertson [Canada]	Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease : sites of action and implications for the pathogenesis of dyskinesias
004673 (1991)	M H Bhatt [Canada] ; S P Keenan ; J A Fleetham ; D B Calne	Pleuropulmonary disease associated with dopamine agonist therapy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022